Genentech, Inc. · South San Francisco, CA United States
| 1 Dna Way | Phone: 650-225-1000 |
| South San Francisco, CA | Fax: 650-225-6000 |
| 94080 | |
| United States | 
Map This Company |
Genentech, Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
"The few, the proud, the profitable" could be Genentech's motto. One of the world's oldest and most successful biotechs (in an industry full of money-losers), the firm has a number of blockbuster cancer therapies based on its antibody (protein) technologies. Its oncology portfolio contains Rituxan, (non-Hodgkin's lymphoma); Avastin (colorectal and lung cancers); Herceptin (breast cancer); Tarceva (lung cancer); Xeloda (metastatic colorectal cancer); and Zelboraf (inoperable melanoma). Other marketed drugs include age-related macular degeneration treatment Lucentis, human growth hormone Nutropin, cystic fibrosis drug Pulmozyme, and asthma drug Xolair. Genentech is wholly owned by Swiss drugmaker
Genentech, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | SubsidiaryHeadquarters |
|---|---|
| Fiscal Year-End | December |
| Employees | 11,174 |
Executives
501 executives listed for Genentech, Inc.'s South San Francisco, CA location.
| Chairman | Arthur Levinson | |
|---|---|---|
| CEO | Ian Clark | |
| EVP Research and Early Development Center | Richard Scheller |